Long Ideas - The price action in shares of Questcor Pharmaceuticals (QCOR) Thursday was telling, with a quick reaction to a negative article published on the company, followed … Continue Reading
Read NowLong Ideas - AcelRx (ACRX) will issue and sell up to 11.5M shares of common stock in the coming weeks, just months ahead of a pivotal period for … Continue Reading
Read NowLong Ideas - Cadence Pharmaceuticals (NASDAQ:CADX) hosted its Investor/Analyst Day on Thursday morning, and gave a compelling presentation as to why Ofirmev, its primary value driver, should continue … Continue Reading
Read NowLong Ideas - With its balance sheet shored up after a recent stock offering, shares trading just off of their 52-week lows, and interim Phase IIb data expected … Continue Reading
Read NowLong Ideas - Questcor Pharmaceuticals (NASDAQ:QCOR) announced a per share cash dividend of $0.20 to shareholders of record on December 14, 2012. The payment is accelerated, as the … Continue Reading
Read NowLong Ideas - Finally, some Vertex (NASDAQ:VRTX) news unrelated to Hepatitis C. Health Canada, the Canadian medicinal regulatory body, approved Vertex’s Kalydeco (ivacaftor) on Monday for the treatment … Continue Reading
Read NowLong Ideas - Many biotechnology companies choose to focus on specific niches of the market that they deem to be the most lucrative. Gilead Sciences (NASDAQ:GILD) is making … Continue Reading
Read Now